Influence of angiotensin-converting enzyme insertion/deletion polymorphism on nitric oxide production in hypertensives and hypercholesterolaemics

Journal of Clinical Pharmacy and Therapeutics

Volumn 36, Issue 2, 2011, Pages 187-193

  He, S W ^a   Huang, H W ^a   Tan, S Q ^a   Fu, X ^b   Su, L L ^a   Peng, D X ^a   Lin, R J ^c   Wong, K S ^d  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c Rongqi Hospital   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

angiotensin converting enzyme; endothelial function; gene polymorphism; nitric oxide; oxidative stress

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANGIOTENSIN II; ANTIOXIDANT; ARGININE; BRADYKININ; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; NITRIC OXIDE; NITRITE; TRIACYLGLYCEROL;

ADULT; ALLELE; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; ATHEROGENESIS; CHINA; ENDOTHELIAL DYSFUNCTION; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; TREATMENT INDICATION; TREATMENT RESPONSE; VASCULAR ENDOTHELIUM;

ADULT; ALLELES; ANGIOTENSIN II; ARGININE; BASE SEQUENCE; BLOOD PRESSURE; CHINA; FEMALE; GENE DELETION; GENOTYPE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INDEL MUTATION; MALE; NITRIC OXIDE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; VASODILATION;

EID: 79952255798     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2010.01176.x     Document Type: Article

References (26)

1. Furchgott RF, Zawadzki JV, (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376. (Pubitemid 11169009)
2. Gewaltig MT, Kojda G, (2002) Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovascular Research, 55, 250-260. (Pubitemid 34775275)
3. Walford G, Loscalzo J, (2003) Nitric oxide in vascular biology. Journal of Thrombosis and Haemostasis, 1, 2112-2118.
4. Jones SP, Bolli R, (2006) The ubiquitous role of nitric oxide in cardioprotection. Journal of Molecular and Cellular Cardiology, 40, 16-23. (Pubitemid 43012113)
5. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F, (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. The Journal of Clinical Investigation, 86, 1343-1346. (Pubitemid 20370444)
6. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F, (1993) Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochemical Journal, 290, 33-40. (Pubitemid 23081197)
7. Danser AH, Schalekamp MA, Bax WA, et al., (1995) Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation, 92, 1387-1388.
8. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC, (2006) ACE polymorphisms. Circulation Research, 98, 1123-1133. (Pubitemid 43948098)
9. Deanfield JE, Halcox JP, Rabelink TJ, (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation, 115, 1285-1295. (Pubitemid 46594773)
10. Celermajer DS, Sorensen KE, Barley J, Jeffrey S, Carter N, Deanfield J, (1994) Angiotensin-converting enzyme genotype is not associated with endothelial dysfunction in subjects without other coronary risk factors. Atherosclerosis, 111, 121-126. (Pubitemid 24330623)
11. Kähönen M, Lehtimäki T, Laaksonen R, et al., (2007) Angiotensin-converting enzyme gene polymorphism and coronary reactivity in young men. Scandinavian Journal of Clinical and Laboratory Investigation, 67, 596-603. (Pubitemid 351411733)
12. Tanriverdi H, Evrengül H, DursunoÄlu D, et al., (2008) Effect of angiotensin converting enzyme genotype on endothelial function in healthy subjects. Anadolu Kardiyoloji Dergisi, 8, 2-6. (Pubitemid 351266058)
13. Dikmen M, Günes HV, Degirmenci I, Ozdemir G, Basaran A, (2006) Are the angiotensin-converting enzyme gene and activity risk factors for stroke? Arquivos de Neuro-Psiquiatria, 64, 211-216. (Pubitemid 43979063)
14. Baylis C, Vallance P, (1998) Measurement of nitrite and nitrate levels in plasma and urine-what does this measure tell us about the activity of the endogenous nitric oxide system? Current Opinion in Nephrology and Hypertension, 7, 59-62. (Pubitemid 28037522)
15. Tsikas D, (2005) Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radical Research, 39, 797-815. (Pubitemid 40975073)
16. Perticone F, Ceravolo R, Maio R, et al., (1998) Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients. Hypertension, 31, 900-905. (Pubitemid 28185565)
17. Schmidt TS, Alp NJ, (2007) Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clinical Science, 113, 47-63. (Pubitemid 47066025)
18. Ohara Y, Peterson TE, Harrison DG, (1993) Hypercholesterolemia increases endothelial superoxide anion production. Journal of Clinical Investigation, 91, 2546-2551. (Pubitemid 23182507)
19. Li H, Förstermann U, (2000) Nitric oxide in the pathogenesis of vascular disease. Journal of Pathology, 190, 244-254. (Pubitemid 30141371)
20. Coelho C, Guerra A, Rego C, et al., (2006) Genetic polymorphisms of angiotensin-I converting enzyme, haptoglobin and angiotensinogen and oxidative stress parameters in 12 to 15-year-old adolescents. Revista Portuguesa de Cardiologia, 25, 677-690. (Pubitemid 44545186)
21. Maas R, Schwedhelm E, Kahl L, et al., (2008) Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia. Clinical Chemistry, 54, 292-300. (Pubitemid 351302630)
22. Ueda S, Weir CJ, Inglis GC, Murray GD, Muir KW, Lees KR, (1995) Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke. Journal of Hypertension, 13, 1597-1601. (Pubitemid 26015782)
23. Kario K, Kanai N, Saito K, Nago N, Matsuo T, Shimada K, (1996) Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation, 93, 1630-1633. (Pubitemid 26131337)
24. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators (2008) Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet, 372, 1174-1183.
25. Yusuf S, Diener HC, Sacco RL, et al., (2008) Telmisartan to prevent recurrent stroke and cardiovascular events. New England Journal of Medicine, 359, 1225-1237.
26. Bai Y, Sun L, Yang T, Sun K, Chen J, Hui R, (2009) Increase in fasting vascular endothelial function after short-term oral l-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition, 89, 77-84.